Response Oncology, Inc.
Response Oncology, Inc.
Aktie · US7612323052 (OTC)
Übersicht
Kein Kurs
n/a
Firmenprofil zu Response Oncology, Inc. Aktie
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
KI-Analyse von Response Oncology, Inc.
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu Response Oncology, Inc.
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name Response Oncology, Inc.
Firma Response Oncology, Inc.
Heimatbörse OTC UTC
ISIN US7612323052
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Care Facilities
CEO Charles E. Sweet
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
IPO Datum 2000-01-03

Ticker Symbole

Name Symbol
Over The Counter ROIX
Weitere Aktien
Investoren, die Response Oncology, Inc. halten, haben auch folgende Aktien im Depot:
BC CRED.SOC.COOP. 16-26
BC CRED.SOC.COOP. 16-26 Anleihe
GEORGIA PWR 24/27
GEORGIA PWR 24/27 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026